IGHE and polyp: Second, while we monitored key clinical parameters such as symptom scores, polyp size, and biomarkers (e.g., total IgE, peripheral eosinophilia), other important markers of inflammation and disease progression, such as specific tissue biopsy analyses, were not incorporated.